{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:08:52Z","timestamp":1762452532031,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Data in Brief"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.dib.2021.107578","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T03:27:59Z","timestamp":1637206079000},"page":"107578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0856-8402","authenticated-orcid":false,"given":"Matthew D.","family":"Krasowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-8833","authenticated-orcid":false,"given":"Anna","family":"Dolezal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8036-8715","authenticated-orcid":false,"given":"Bryan W.","family":"Steussy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Gailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin W.","family":"Darbro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.dib.2021.107578_bib0001","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2015.03.027","article-title":"``Non-classical'' paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to ``classical'' syndromes-more frequent than expected","volume":"352","author":"Berger","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"16","key":"10.1016\/j.dib.2021.107578_bib0002","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"1-2","key":"10.1016\/j.dib.2021.107578_bib0003","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jns.2013.09.031","article-title":"Presence of paraneoplastic antibodies in non-carcinomatous patients with neurological involvements of unknown cause","volume":"335","author":"Yanagihashi","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.dib.2021.107578_bib0004","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/clinchem\/hvaa254","article-title":"Neural antibody testing in patients with suspected autoimmune encephalitis","volume":"66","author":"Budhram","year":"2020","journal-title":"Clin. Chem."},{"issue":"14","key":"10.1016\/j.dib.2021.107578_bib0005","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1158\/1078-0432.CCR-14-0652","article-title":"Neural autoantibody clusters aid diagnosis of cancer","volume":"20","author":"Horta","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.dib.2021.107578_bib0006","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2016.06.006","article-title":"Autoantibody diversity in paraneoplastic syndromes and related disorders: the need for a more guided screening approach","volume":"459","author":"Tebo","year":"2016","journal-title":"Clin. Chim. Acta"},{"issue":"Suppl 2","key":"10.1016\/j.dib.2021.107578_bib0007","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10072-017-3031-5","article-title":"Diagnostics of paraneoplastic neurological syndromes","volume":"38","author":"Zoccarato","year":"2017","journal-title":"Neurol. Sci."},{"issue":"6","key":"10.1016\/j.dib.2021.107578_bib0008","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/00207454.2016.1207644","article-title":"Paraneoplastic autoantibody panels: sensitivity and specificity, a retrospective cohort","volume":"127","author":"Albadareen","year":"2017","journal-title":"Int. J. Neurosci."},{"issue":"13","key":"10.1016\/j.dib.2021.107578_bib0009","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1212\/WNL.0000000000008180","article-title":"Author response: Unintended consequences of Mayo paraneoplastic evaluations","volume":"93","author":"Callaghan","year":"2019","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.dib.2021.107578_bib0010","doi-asserted-by":"crossref","first-page":"e2057","DOI":"10.1212\/WNL.0000000000006577","article-title":"Unintended consequences of Mayo paraneoplastic evaluations","volume":"91","author":"Ebright","year":"2018","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.dib.2021.107578_bib0011","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1212\/WNL.0000000000008174","article-title":"Reader response: unintended consequences of Mayo paraneoplastic evaluations","volume":"93","author":"Kelkar","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.dib.2021.107578_bib0012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1373\/jalm.2018.028480","article-title":"Utilization review of paraneoplastic neurological syndrome antibody screening panels: experience at a tertiary academic health center","volume":"4","author":"Kim","year":"2019","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.dib.2021.107578_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2019.105545","article-title":"The use, misuse and abuse of paraneoplastic panels in neurological disorders. A retrospective study","volume":"186","author":"Zidan","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.dib.2021.107578_bib0014","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1373\/jalm.2019.029165","article-title":"Hermes Tacker D: Clinical utility and performance in test utilization interventions for paraneoplastic antibody panel orders: a delicate balance","volume":"4","year":"2019","journal-title":"J. Appl. Lab. Med."},{"issue":"13","key":"10.1016\/j.dib.2021.107578_bib0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1212\/WNL.0000000000008179","article-title":"Reader response: Unintended consequences of Mayo paraneoplastic evaluations","volume":"93","author":"Pittock","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.dib.2021.107578_bib0016","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clim.2018.12.007","article-title":"A large screen for paraneoplastic neurological autoantibodies; diagnosis and predictive values","volume":"199","author":"Seluk","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.dib.2021.107578_bib0017","article-title":"Serum tumor markers in paraneoplastic neurologic syndromes: a systematic review of guidelines","volume":"11","author":"Trevisiol","year":"2020","journal-title":"Front. Neurol."}],"container-title":["Data in Brief"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352340921008532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352340921008532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:01:51Z","timestamp":1762452111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352340921008532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":17,"alternative-id":["S2352340921008532"],"URL":"https:\/\/doi.org\/10.1016\/j.dib.2021.107578","relation":{},"ISSN":["2352-3409"],"issn-type":[{"type":"print","value":"2352-3409"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center","name":"articletitle","label":"Article Title"},{"value":"Data in Brief","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dib.2021.107578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107578"}}